High Rate of Thromboembolic Events in the Last Year of Life of Cancer Patients: A Registry Study.

BACKGROUND/OBJECTIVES: Venous thromboembolism (VTE) is associated with cancer, but we wanted to show VTE data for the last year of life, adjusting for age, sex, socioeconomic status and comorbidities. We also wanted to study the possible increase in VTE month by month, as well as time trends from 2015 to 2023.

METHODS

A cohort of 27,423 deceased people with cancer were analyzed with -tests, chi-square tests and binary logistic regression models.

RESULTS

In total, 13.6% had at least one VTE episode during the last year of life and the VTE rate increased month by month ( < 0.0001). In adjusted models, higher VTE rates were associated with younger age and being a woman ( < 0.0001), both for all VTE as well as separately for pulmonary embolism (PE). The VTE rate increased by 47% from 11.1% in 2015 to 16.3% in 2023, and with significant differences for the pre-COVID-19 and COVID-19 years (i.e., 2015-2019 compared to 2020-2023, < 0.0001).

CONCLUSIONS

VTE is common in the last year of life and increases month by month. Higher frequencies are associated with female sex but especially with being younger, or having certain cancer forms such as pancreatic, gynecologic or lung cancer. The rate of VTE increased from 2015 to 2023. This is of interest as VTE has been associated with higher treatment intensity and with poorer prognosis and should be considered in the decision-making process.